Search

everythinglearnresearchcommunity

for

Search:↓

FDG PET/CT scans can change cancer treatment plans for dogs.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

Finasteride effectively treats male hair loss, increasing length and thickness.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The healthcare for transgender veterans could be better with a more unified team approach.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Pomegranate is beneficial in various medical fields.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

FDG PET/CT can improve cancer treatment plans in dogs.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Older men with postoperative urinary retention are more likely to need future bladder procedures.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.